Deep learning imaging analytics company Zebra Medical Vision has received government support through generous grants from the Israel Innovation Authority.
Image: Zebra Medical Vision is granted three Israeli government grants to deploy medical Imaging AI at scale. Photo: courtesy of Zebra-Med.
Zebra Medical Vision will put its AI algorithms to use in critical emergency situations at Ichilov Hospital, and will work to detect early signs of breast cancer and osteoporosis at Macabi and Clalit HMOs. These three health providers manage over 90% of Israeli patients.
The emergency room is a bottleneck for deciphering and diagnosing medical cases, and therefore requires rapid and efficient interpretation using artificial intelligence. Zebra-Med’s technology can help radiologists prioritize by scanning their entire queue and flagging those that need immediate attention, such as acute brain bleeds in head CT scans or Pneumothorax in chest X-rays.
Additionally, Zebra Medical Vision will provide its AI predictive imaging analysis in collaboration with Israel’s largest HMOs to risk stratify large populations and enable early detection of breast cancer and osteoporosis.
Zebra Medical Vision will put its AI algorithms to use in three major Israeli medical institutions:
Ichilov Hospital, Israel’s largest ER hospital: Zebra-Med will incorporate AI algorithms to prioritize radiologists’ worklists and hasten the rate at which life-threatening issues are detected in emergency situations
Maccabi Healthcare Services, owner of Israel’s largest private medical centers: Zebra-Med will provide its deep learning based breast cancer algorithm as a “second reader” to reduce the risk of misdiagnosis.
Clalit Health Services, Israel’s largest HMO group: Zebra-Med will apply its technology to detect early signs of osteoporosis and heart disease and alert the doctors in the community to provide preventative treatment
“As a global leading ER center, we put significant emphasis on being on the cutting edge in terms of technology solutions that will empower our team,” added Prof. Ronni Gamzu, CEO of Tel Aviv Sourasky Medical Center. “We selected Zebra-Med’s AI solutions to help our team perform faster and better diagnostics and we are certain that hundreds of thousands of patients will benefit from this new technology.”
“The combination of man and machine brings us to new heights in the treatment of cancer,” said Professor Varda Shalev, CEO of The Moris Kahn & Maccabi Institute for Research & Innovation, “The integration of Zebra allows early, accurate detection of breast cancer, which is key to successful treatment.”
“Our team is humbled by the credit that was given us by the Innovation authority and is committed to providing the best solutions to our local care providers,” noted Eyal Gura, Zebra Medical Vision’s Co-Founder and CEO. “In 2020, the majority of the people around us, including our loved ones, will be impacted by the tools we are creating. There is nothing more satisfying than that for our team.”
“The cooperation between Clalit and Zebra Medical Vision enables Clalit to conduct comprehensive research on large populations that have undergone imaging tests, while continuing to lead the implementation of technological innovation to advance the health of its policyholders. Clalit is working to bring its policyholders the most advanced technology, to both improve and maintain their health,” said Prof. Ran Blitzer, Director of the Clalit Research Institute.
CEO, Israel Innovation Authority, Aharon Aharon: ØThe Innovation Authority believes digital health to be of imperative and strategic growth engine for the entire Israeli economy, hence promoted the Pilot Program with Government Companies. Zebra Medical Vision, selected as one of the winners in this program, represents the flagship that will helps substantiate and promote digital health in Israel.Ø
Zebra-Med’s data and research platform has already yielded AI imaging insights that have been deployed over millions of scans. Last year, Zebra received 7 CE marks and for its various algorithms and 510(k) FDA clearance for its Coronary Calcium Scoring algorithm allowing the company to expand its footprint in the US and EU. In addition to the Israel Innovation Authority grants, Zebra has also raised over $50 million from a range of investors over three funding rounds.
Source: Company Press Release